Accessibility Remediation
If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.
Authors
- Tongqing Zhou, Vaccine Research Center NIAID, Bethesda, Maryland
- Ling Xu, Vaccine Research Center NIAID, Bethesda, Maryland
- Barna Dey, Vaccine Research Center NIAID, Bethesda, Maryland
- Ann J. Hessell, The Scripps Research Institute, La Jolla, California
- Shahzad Majeed, Vaccine Research Center NIAID, Bethesda, Maryland,
- Donald Van Ryk, Laboratory of Immunoregulation NIAID, Bethesda, Maryland
- Shi-Hua Xiang, University of Nebraska-LincolnFollow
- Xinzhen Yang, Dana-Farber Cancer Institute, Boston, Massachusetts
- Mei-Yun Zhang, Center for Cancer Research and Nanobiology Program NCI, Frederick, Maryland
- Michael B. Zwick, The Scripps Research Institute, La Jolla, California
- James Arthos, Laboratory of Immunoregulation NIAID, Bethesda, Maryland
- Dennis R. Burton, The Scripps Research Institute, La Jolla, California
- Dimiter S. Dimitrov, Center for Cancer Research and Nanobiology Program NCI, Frederick, Maryland
- Joseph Sodroski, Harvard Medical SchoolFollow
- Richard Wyatt, Vaccine Research Center NIAID, Bethesda, Maryland
- Gary J. Nabel, Vaccine Research Center NIAID, Bethesda, Maryland
- Peter D. Kwong, Vaccine Research Center NIAID, Bethesda, Maryland
Date of this Version
2006
Citation
Retrovirology 2006, 3(Suppl 1):S22
DOWNLOADS
Since March 14, 2016
COinS
Comments
© 2006 Zhou et al; licensee BioMed Central Ltd.